PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.21%
Revenue growth above 1.5x AVGO's 0.98%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
20.51%
Gross profit growth above 1.5x AVGO's 2.67%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.09%
EBIT growth above 1.5x AVGO's 11.49%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
30.09%
Operating income growth above 1.5x AVGO's 11.49%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
43.74%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
40.00%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
43.48%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.01%
Share reduction more than 1.5x AVGO's 2.14%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.79%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-1.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
64.11%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
67.13%
FCF growth above 1.5x AVGO's 0.14%. David Dodd would verify if the firm’s strategic investments yield superior returns.
117.46%
10Y revenue/share CAGR under 50% of AVGO's 473.97%. Michael Burry would suspect a lasting competitive disadvantage.
125.94%
5Y revenue/share CAGR under 50% of AVGO's 353.42%. Michael Burry would suspect a significant competitive gap or product weakness.
95.42%
3Y revenue/share CAGR 1.25-1.5x AVGO's 79.84%. Bruce Berkowitz might see better product or regional expansions than the competitor.
180.13%
10Y OCF/share CAGR under 50% of AVGO's 1763.79%. Michael Burry would worry about a persistent underperformance in cash creation.
557.98%
5Y OCF/share CAGR at 50-75% of AVGO's 845.94%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
387.45%
3Y OCF/share CAGR above 1.5x AVGO's 133.92%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
227.27%
Below 50% of AVGO's 1252.77%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
313.67%
5Y net income/share CAGR at 75-90% of AVGO's 385.76%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
340.13%
3Y net income/share CAGR above 1.5x AVGO's 207.11%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
135.92%
Equity/share CAGR of 135.92% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
38.81%
Below 50% of AVGO's 480.81%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
37.24%
Below 50% of AVGO's 295.19%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.63%
Below 50% of AVGO's 346.80%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.79%
Firm’s AR is declining while AVGO shows 9.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.23%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.55%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.29%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-3.04%
We’re deleveraging while AVGO stands at 0.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.06%
R&D growth drastically higher vs. AVGO's 2.46%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
7.07%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.